Investors

Latest results

From quarterly updates to key announcements, here you can access all GSK investor-related information.

Scroll to explore

We’re confident in our future

Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.

Latest announcements and results

Emma Walmsley in a blue dress

2022 Third quarter results announcement

Quarterly results
02 November 2022

We announced our third quarter results for the period which ended 30 September 2022 on Wednesday 2 November.

 

DNA science image

GSK publishes Prospectus and Circular

Press release

We have published the Prospectus and Circular for the proposed demerger of our Consumer Healthcare business to form Haleon.

 

Immuno oncology science image

Completion of the demerger of Haleon and share consolidation of GSK

Press release
18 July 2022

GSK plc has today completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group. 

Shingles cell

Completion of GSK Share Consolidation

Press release
18 July 2022

GSK plc is pleased to announce that further to the Circular and Notice of General Meeting published by GSK on 1 June 2022, and following the announcements of 6 July 2022 that shareholder approval was granted at the GSK General Meeting and of 18 July 2022 that GSK has completed the demerger of the Consumer Healthcare business from the GSK Group to form Haleon.

Key dates

09-12
Jan

J.P. Morgan 41st Annual Healthcare Conference 2023

We will attend the J.P. Morgan 41st Annual Healthcare Conference in San Francisco, CA, USA.

01
Feb

Q4 2022 results

We will announce our full year and fourth quarter 2022 results on Wednesday 1 February 2023.

two scientists talking

Get in touch with our investor team

Back to top